Stock Events

Stock Events

NeuroSense Therapeutics (NRSN) Q4 2024 Earnings

18DecConfirmed

Q1 2024

Q2 2024

Q3 2024

Q4 2024

-0.35

-0.25

-0.15

-0.05

Details

Expected EPS

-0.11

Actual EPS

-0.12

Surprise EPS

-0.01

Surprise Percent

+9.09%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of -0.12 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.